News

SNS01-T met the criteria for Stable Disease in two of the three evaluable patients that comprised first cohort. No drug-related serious adverse events or dose limiting toxicities were

The Phase II trial will be potentially followed by a larger multi-national Phase III study in the US, Europe and India, according to the company. Pluristem chairman, president

The double-blind, dose escalation trial will enrol approximately 150 volunteers with moderate-to-severe HSV-2 infection who are otherwise healthy. The placebo-controlled study is designed to evaluate the safety and

Cordlife Group CEO Jeremy Yee said in recent years Cordlife has successfully brought the benefits of umbilical cord blood banking to numerous people in multiple regions across China.

The acquisition will enable IMS Health’s clients to enhance the speed, efficiency and cost-effectiveness of their trial planning and management activities. As part of the acquisition, IMS will

According to the information received from the contract laboratory that performed the studies, namely, KARD Scientific, FluCide drug candidate designed for oral administration has shown strong efficacy in

With the IND approval, APX001/SSS07 will be studied in clinical trials for the treatment of autoimmune and inflammatory diseases. Apexigen president and CEO Dr. Xiaodong Yang said, "It

According to the transaction, Biogen will invest in Regulus and make upfront and milestone payments. Biogen corporate development executive vice president Steven Holtzman said that utilizing new technology

The trial will evaluate the safety and immunogenicity of the H5N1 vaccine, combined with IDRI’s Glucopyranosyl Lipid A ("GLA") adjuvant. Each study participant in the trial will receive